Therefore, growth curves of untreated MDS/CMML and AML cells were correlated with the corresponding surviving fractions of talazoparib and APE1 inhibitor III treated MDS/CMML and AML cells (Figure 1C,D). Here, APEX1 is linked to myelodysplastic syndrome.